Nevertheless, aldosterone displays a stronger binding potency for GPER than estrogen; thus, under conditions of primary aldosteronism or hyperaldosteronemia-induced hypertension, inhibiting the activity of GPER would have a better effect on achieving blood pressure control and targeting organ injury. This evidence concerns the gene GPER1 and primary aldosteronism.